Single-agent vorasidenib or ivosidenib led to brain penetrance and 2-hydroxyglutarate suppression in patients with low-grade glioma who harbor IDH1 mutations. Read More >>
OncLive houses thousands of videos that provide updates and information. See more Videos
Resource Guides
Glioblastoma Multiforme
Resource Guide
A collection of websites that provide information and support for patients with brain cancer and the oncology professionals who treat them. View Guide >>>
Brain Cancer
Resource Guide
A collection of websites that provide information and support for patients with brain cancer and the oncology professionals who treat them. View Guide >>>
Brain Tumor
Support and Assistance Guide
A collection of websites that provide information and support for patients with brain cancer and the oncology professionals who treat them. View Guide >>>
Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now